Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Buy SPY Stock on Weakness

By Chris Lau, InvestorPlace Contributor

Weak technology stocks hurt the S&P 500 in 2022, a trend that will reverse as markets settle with higher interest rates. Buy SPY stock now.

7 Tech Stocks to Buy as Apple, Intel, and Microsoft Lead Russia Boycotts

By Chris Lau, InvestorPlace Contributor

Powerful technology firms are taking a stand, which not only improves their brand power, but indirectly helps Ukraine fend off its invaders.

Why Buy Taiwan Semiconductor Stock At Every Dip

By Chris Lau, InvestorPlace Contributor

Geopolitical risks cloud TSM stock for now but as markets realize strong demand in the quarter and year ahead, shares will rebound.

Take a Small Position in Amazon Stock Now

By Chris Lau, InvestorPlace Contributor

Amazon has an aggressive stock split ahead to attract buyers while its core AWS business thrives, fueling growth.

Why You Should Avoid Nio Stock As Delisting Worries Mount

By Chris Lau, InvestorPlace Contributor

Didi’s failed Hong Kong listing spooked Nio investors, renewing fears that the SEC crackdown would lead to a Nio stock delisting.

Load More